Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Clorazepate dipotassium - Generic Drug Details

« Back to Dashboard

What are the generic sources for clorazepate dipotassium and what is the scope of clorazepate dipotassium freedom to operate?

Clorazepate dipotassium
is the generic ingredient in four branded drugs marketed by Quantum Pharmics, Recordati Rare, Mylan, Sun Pharm Inds Ltd, Aurolife Pharma Llc, Lederle, Purepac Pharm, Gd Searle Llc, Warner Chilcott, Am Therap, Taro Pharm, Dava Pharms Inc, Usl Pharma, Watson Labs, Able, and Alra, and is included in sixty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for clorazepate dipotassium. Eleven suppliers are listed for this compound.

Summary for Generic Name: clorazepate dipotassium

Drug Master File Entries: see list8
Suppliers / Packagers: see list11
Bulk Api Vendors: see list24
Patent Applications: see list670
Drug Prices:see low prices
DailyMed Link:clorazepate dipotassium at DailyMed

Pharmacology for Ingredient: clorazepate dipotassium

Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
clorazepate dipotassium
TABLET;ORAL072013-001Dec 15, 1987DISCNNoNo► Subscribe► Subscribe
Recordati Rare
clorazepate dipotassium
TABLET;ORAL017105-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Dava Pharms Inc
clorazepate dipotassium
CAPSULE;ORAL071742-001Dec 14, 1987DISCNNoNo► Subscribe► Subscribe
clorazepate dipotassium
TABLET;ORAL071858-002Jul 17, 1987ABRXNoNo► Subscribe► Subscribe
Watson Labs
clorazepate dipotassium
CAPSULE;ORAL071860-001Mar 15, 1988DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus